Health Care/Hospital
Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial of LNK01004 Ointment for Vitiligo
HANGZHOU, China, SHANGHAI and BOSTON, July 9, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today announced that the first patient was successfully dosed on June 30 in...
2026-07-09 08:00
4753
On the Eve of BIO 2026, Chinese Innovative Assets Trigger a New Wave of Global Collaborations
SAN DIEGO , July 8, 2026 /PRNewswire/ -- On the eve of the highly anticipated BIO International Convention 2026, theBIOSeedin Summer Innovation Partnering Summit successfully took place in San Diego. Hosted by bioSeedin and proudly supported by strategic partners Thermo Fisher Scientific and ACRO...
2026-07-09 00:00
3315
Tsingke Highlights AI-Driven CLDN18.2 Antibody Discovery at AIS 2026
MONTPELLIER, France, July 8, 2026 /PRNewswire/ -- Tsingke, a provider of integrated life science research solutions, participated in the Antibody Industrial Symposium (AIS) 2026, one of Europe's leading conferences dedicated to therapeutic antibodies and biotherapeutics. At the event, the company...
2026-07-08 22:17
3324
Vermon launches Vermon Group, accelerating its growth and expanding its offerings
Vermon Group opens a new chapter with the acquisition of Moduleus, the opening of TransducerWorks' new U.S. manufacturing facility, and the launch of a coordinated Group platform designed to move faster, deliver more, and stay close to customers. TOURS, France, July 8, 2026 /PRNewswire/ -- Vermo...
2026-07-08 22:02
3316
Altruist Biologics' Hangzhou Antibody-Drug Conjugate Facility Receives Provincial Regulatory Approval for Segmented Production
* First antibody-drug conjugate facility to receive three provincial regulatory approvals for segmented manufacturing. * Demonstrated a unified quality system, strict risk assessment protocols, and compliance with rigorous regulatory requirements from development through commercialization. HA...
2026-07-08 22:00
3629
Global Care Economy Set to Create Significant Growth Opportunities as Care-Dependent Population Reaches up to 4.6 Billion by 2035
Rapid population ageing and care worker shortages are accelerating demand for next-generation care infrastructure, AgeTech, and integrated care ecosystems LONDON, July 8, 2026 /PRNewswire/ -- Frost & Sullivan's latest analysis, The Global Care Economy, Transformations and Opportunities to 2035, r...
2026-07-08 22:00
3643
Seegene Launches Industry's First Global Million Clinical Study to Shape New Disease-Specific Testing Standards
* Seegene is launching the Global Million Clinical Study at the scale of one million test cases to shape disease-specific testing standards. * The study is designed to evaluate the clinical utility of syndromic PCR testing approaches and build real-world scientific evidence to support better-...
2026-07-08 21:00
3927
BB Energy Secures Three Additional South Sudan Crude Oil Cargoes
LONDON, July 8, 2026 /PRNewswire/ -- BB Energy secures three additional crude oil cargos from the Republic of South Sudan. BB Energy is pleased to announce that it has been awarded three additional crude oil cargoes by the Republic of South Sudan, scheduled for delivery in August, September and ...
2026-07-08 17:00
3043
WuXi Biologics Achieves MSCI ESG AAA Rating and MSCI Selection Indexes Inclusion for Fourth Consecutive Year
* Maintained the highest MSCI AAA ESG Rating for the fourth consecutive year under the new ESG Model 5.0 (2026) * Included in the MSCI ESG Selection Indexes for the fourth consecutive year * Leader in Green CRDMO solutions for a healthier future SHANGHAI, July 8, 2026 /PRNewswire/ -- WuXi Bi...
2026-07-08 15:15
5836
MEDIPOST Inc. Treats First U.S. Participant in Phase III Trial of Umbilical Cord Stem Cell Therapy for Symptomatic Cartilage Defects Due to Knee Osteoarthritis
U.S. Phase III Trial Expands Clinical Investigation of Stem Cell Therapy for Knee Cartilage Defects CAMBRIDGE, Mass., July 8, 2026 /PRNewswire/ -- MEDIPOST Inc., a biotechnology company developing allogeneic, umbilical cord blood-derived stem cell therapies for inflammation-driven degenerative d...
2026-07-08 10:43
3469
Merz Aesthetics Presents Ultherapy Mask - PDRN Peptide Radiance and Launches its 2026 Campaign at the Ultherapy PRIME Soirée in Malaysia
* Merz Aesthetics introduces its 2026 campaign "See My Skin, Lift My Way", celebrating individuality, authenticity and the belief that every skin journey is unique, during an event in Malaysia * Media, key opinion leaders and aesthetic physicians from across the region were able to experience...
2026-07-08 10:38
4530
Wegovy® (semaglutide) label updated in Singapore with higher dose supported by STEP UP evidence
* Up to one in three participants on semaglutide 7.2 mg achieved at least 25% weight loss over 72 weeks * Mean weight loss with semaglutide 7.2 mg reached 21%, reflecting overall treatment efficacy * Up to 84% of weight loss was driven by reductions in fat mass, supporting meaningful improv...
2026-07-08 09:22
2966
dsm-firmenich awards 2026 Nutrition Research Grant to five projects investigating the role of nutrients and bio-actives in supporting healthy longevity in Asia Pacific
Record number of grant applications reflect growing interest in the emerging issue of healthy aging in Asia Pacific, where one in four people will be over 60 by 2050[1]. SINGAPORE, July 8, 2026 /PRNewswire/ -- dsm-firmenich, innovators in nutrition, health, and beauty, today awarded the second r...
2026-07-08 09:00
3371
OTR Therapeutics Enters Strategic Collaboration with LG Chem to Accelerate Development of Novel Oncology Therapies
SHANGHAI, July 7, 2026 /PRNewswire/ -- OTR Therapeutics, a clinical-stage biotechnology company dedicated to transforming early-stage innovations into globally impactful therapies, today announced that it has entered into a strategic collaboration agreement with LG Chem, a leading global company ...
2026-07-08 07:00
2793
More Than 8,000 Entrepreneurs from 30 Countries Gather in Malaysia for QNET's Global V-Convention 2026
Global Flagship convention reinforces responsible entrepreneurship, leadership development and innovation while unveiling new wellness, lifestyle and technology products PENANG, Malaysia, July 8, 2026 /PRNewswire/ -- Held under the theme "Reform. Perform. Transform.", V-Convention 2026 brought t...
2026-07-08 02:23
3380
Bambu Lab Announces 48-Hour Charity Fundraiser to Support Venezuela Earthquake Relief
AUSTIN, Texas, July 7, 2026 /PRNewswire/ -- Building on the ongoing relief efforts of Bambu Lab LATAM, including a USD 50,000 contribution toward earthquake recovery in Venezuela, Bambu Lab today announced a further step: a 48-hour community initiative beginning July 13 at 8:00 a.m. UTC−4, 2026. ...
2026-07-08 00:00
3379
Insilico Initiates Phase III Clinical Trial for Rentosertib, Its AI-Empowered TNIK Inhibitor for Idiopathic Pulmonary Fibrosis
* Potentially first-in-class oral TNIK inhibitor advances into late-stage development after milestones marked by vital peer-reviewed papers: the discovery-to-clinic journey in Nature Biotechnology, and positive Phase IIa clinical results in Nature Medicine * Rentosertib represents a novel mec...
2026-07-07 21:43
5076
NYSE Content Update: Teradata AI Report Surveys 1,000 Global Tech + Data Leaders
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, July 7, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins...
2026-07-07 20:55
7953
Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones
MUMBAI, India, July 7, 2026 /PRNewswire/ -- Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, released its Annual Report for FY2026, highlighting a year of strengthening its global platform, investing in differentiated capab...
2026-07-07 20:50
4746
Cambrex, Snapdragon Chemistry, and Q1 Scientific Recognized for Innovation and Sustainability in Pharma
EAST RUTHERFORD, N.J., July 7, 2026 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), proudly announces that Snapdragon Chemistry, a Cambrex company, together with NewAmsterdam Pharma, has received the American Chemical Society's 2026 Green Chem...
2026-07-07 20:00
3385
Week's Top Stories
Most Reposted
SMU School of Accountancy launches Applied AI Track for next generation of accounting and finance professionals
[Picked up by 282 media titles]
2026-10-07 11:50DayOne Files Registration Statement for Proposed Initial Public Offering
[Picked up by 279 media titles]
2026-10-06 05:28Agoda Partners with Marina Bay Sands on Bespoke Flagship Store for Experience-Led Travel
[Picked up by 277 media titles]
2026-10-08 09:50
New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 274 media titles]
2026-10-09 13:21Southeast Asia's China travel map is widening, Traveloka platform data shows
[Picked up by 263 media titles]
2026-10-05 11:51Most Read
Nuix Neo Generative AI Framework
2026-10-08 08:02
9127
Silicon Quantum Computing Named to Fast Company's 2026 Next Big Things in Tech List
2026-10-06 19:38
8163
DayOne Files Registration Statement for Proposed Initial Public Offering
2026-10-06 05:28
7981